A new therapy for the treatment of myeloproliferative diseases

The present invention describes the neural mechanisms regulating the haematopoietic niche, regulatory mechanisms that are impaired in myeloproliferative neoplasms (MPN) and that contribute to the disease´s pathogenesis, thereby emerging as new therapeutic targets.

  • Number P201330677
  • Priority date 10/05/2013
  • Applicants CNIC
  • Inventors Simón Méndez Ferrer, Lorena Arranz Salas, Joan Isern Marín
  • Download documents